Live Breaking News & Updates on Halugen Life Science
Stay updated with breaking news from Halugen life science. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HaluGen Life Sciences' test evaluates an individual's overall sensitivity and risk profile associated with psychedelic-assisted therapy Vancouver, British Columbia (Newsfile Corp. - June 10, 2021) - ....
Entheon Biomedical Corp.: Entheon Biomedical Lists on OTCQB Venture Market Entheon or the Company ), a biotechnology company focused on developing psychedelic medicines to treat addiction, is pleased to announce that it has been approved for trading on the OTCQB Venture Market ( OTCQB ) effective May 5, 2021. We are thrilled to be up-listing on to the OTCQB, which will allow for greater engagement with our U.S. investor base. As we advance our DMT addiction therapy program toward human trials, continue R&D on our diagnostic and patient-monitoring platform, and scale up commercial availability of our subsidiary, HaluGen Life Science s Psychedelics Genetic Test, we are pleased to be gaining increased visibility and investor access within the U.S. market, said Timothy Ko, CEO of Entheon. ....
Entheon Biomedical Lists on OTCQB Venture Market streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.